This identified all tumours with germline BRCA1/2 loss (22 cases out of 560), 22 further cases of somatic BRCA1/2 loss and 47 tumours with BRCA1/2 deficiency where no mutation was detected, but it was limited by the requirement of whole-genome sequencing for data input. The gene discussed is BRCA1; the disease is neoplasm.